MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

CAH · NYSE

Cardinal Health, Inc.

Health Care · Other Pharmaceuticals

Reference price$232.51As of Jul 28, 2026
Market capitalization$54.46B
52-week range$137.75–$243.21
S&P 500 portfolio weight0.08%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$215.00-7.5% vs. reference
Average$252.55+8.6% vs. reference
High$275.00+18.3% vs. reference
10 Buy1 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 11, 2026Jun 2026
Consensus EPS$2.427 estimates
Expected range$2.40–$2.45Low to high EPS
Jun 2026$10.77Street EPS consensus
Jun 2027$12.04Street EPS consensus
Jun 2028$13.36Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Jun 30, 2025.

MetricCurrentPrior
Revenue-1.9% YoY$223B$227B
Operating income$2.28B$1.24B
Net income$1.56B$0.85B
Operating cash flow$2.4B$3.76B
Capital expenditures($0.55B)($0.51B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Why Cardinal Health (CAH) Outpaced the Stock Market Today

Zacks

Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market

Zacks

OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.